NRAS and thyroid tumor: Rivera et al. examined eight cases of noninvasive encapsulated thyroid tumors of follicular cell origin with high-grade poorly differentiated features and found no recurrence after a median follow-up of 11.9 years and NRAS codon 61 mutations to be the most frequent oncogenic event [29].